Image

Exercise Intensity

Exercise Intensity

Recruiting
18-79 years
All
Phase N/A

Powered by AI

Overview

Patients receiving regular hemodialysis (HD) treatments are at a higher risk of cardiovascular events and death as HD can cause a decrease in the pumping of the heart during treatment called 'stunning'. Intradialytic exercise has emerged as a safe and effective non-drug approach to improve cardiovascular health and is now recommended for patients undergoing HD. It is currently advised that HD patients engage in at least 30 minutes of moderate to vigorous exercise three times per week. This study will evaluate the impact of exercise intensity in the HD population and determine if high impact exercise can offer better protection to the heart against HD-induced myocardial stunning.

Description

This will be the first randomized, cross-controlled trial evaluating the impact of exercise intensity in the HD population. If the efficacy of cardiovascular protection is proven, it could be developed as a therapeutic option in the dialysis population.

Eligibility

Inclusion Criteria:

  • Must be on chronic hemodialysis for at least 3 months
  • Age ≥ 18 years of age
  • Willing and able to provide informed consent

Exclusion Criteria:

  • Regular vigorous exercise outside hemodialysis
  • > 79 years of age
  • Intradialytic exercise in the past 3 months
  • Poor echogenicity
  • Acute coronary syndrome in the past 3 months
  • Unstable arrhythmia/angina
  • Shortness of breath at rest or with minimal activity
  • Symptomatic hypoglycemia (>2x/week in the week prior to enrolment)
  • Symptomatic peripheral arterial disease
  • Unable or deemed unsafe to exercise for any reason
  • Severe musculoskeletal or orthopedic conditions
  • Aortic stenosis
  • Hypertrophic cardiopathy
  • Severe pulmonary hypertension
  • Symptomatic hypertension

Study details
    Dialysis
    Cardioprotection

NCT07119593

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.